Cure My Disease

Don't miss your cure!

 Log in / Sign up

Healthy volunteers test two drug versions for similarity

NCT ID NCT07256600

Completed Knowledge-focused Sponsor: Daewoong Pharmaceutical Co. LTD. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed Phase 1 trial enrolled 70 healthy adults to compare two tablet formulations of the same drug, DWJ1445 and DWC202506. Participants received a single dose of each in random order, and researchers measured drug levels in the blood to check if the two versions are absorbed similarly. The study was not designed to treat any condition, but to gather information for future drug development.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
DWJ1445 and DWC202506 (two tablet formulations of the same drug)
What this could lead to
If the two formulations are shown to be bioequivalent, it could support using a new version of the drug in future studies or as a generic alternative.
What could go wrong
This is a very early, small study in healthy volunteers, not patients. It only checks how the drug is absorbed, not whether it treats any disease. Results may not predict real-world effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY SUBJECTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY SUBJECTS

Contacts and locations

Locations

  • H Plus Yangji Hospital

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.